PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Nov-2019 Epigenomics AG Reports Financial Results for the First Nine Months 2019 Epigenomics AG
19-Nov-2019 aap receives further funding of up to EUR 2.7 million for its innovative antibacterial silver coating technology aap Implantate AG
19-Nov-2019 Newron Receives FDA Rare Pediatric Disease Designation for Sarizotan for the Treatment of Rett Syndrome Newron Pharmaceuticals S.p.A.
19-Nov-2019 SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ABEO Pomerantz LLP
18-Nov-2019 SHAREHOLDER ALERT - Lipocine Inc. (LPCN) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: January 14, 2020 Bronstein, Gewirtz & Grossman, LLC
18-Nov-2019 MorphoSys' tafasitamab B-MIND DLBCL study successfully passed futility analysis (news with additional features) MorphoSys AG
18-Nov-2019 Ad hoc: MorphoSys' tafasitamab B-MIND DLBCL study successfully passed futility analysis MorphoSys AG
18-Nov-2019 Castor Establishes Advisory Board of Industry Leaders to Maximize the Impact of its Clinical Data Platform Castor
18-Nov-2019 Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea Jazz Pharmaceuticals
18-Nov-2019 Bimekizumab Positive Results Confirmed in Second Phase 3 Psoriasis Study UCB
18-Nov-2019 Novartis receives positive CHMP opinion for Mayzent® (siponimod), the first and only oral treatment for secondary progressive multiple sclerosis with active disease Novartis
18-Nov-2019 Securecell Introduces Sephara, a Novel, Silicon-Based In-Situ Filtration Membrane Securecell
18-Nov-2019 Consistent effects of FARXIGA in heart failure patients with reduced ejection fraction shown in new analyses from landmark Phase III DAPA-HF trial AstraZeneca
18-Nov-2019 Time for an evidence review of OTC analgesics? Havas SO
18-Nov-2019 PTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient Identification PTC Therapeutics
18-Nov-2019 Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock Phio Pharmaceuticals Corp.
18-Nov-2019 Soligenix to Present at the PCG Spotlight Series Conference Soligenix, Inc.
18-Nov-2019 Alkermes to Acquire Rodin Therapeutics Alkermes plc
18-Nov-2019 Abzena Showcases Discovery and Developability Services at PEGS Europe 2019 Abzena
18-Nov-2019 Exclusive speaker interview released for SMi’s AI in Drug Discovery Conference 2020 SMi Group